Clinical Trials Directory

Trials / Completed

CompletedNCT03860129

Different Volatile Anaesthetics and the Depth of Long Term ICU Sedation

Depth of Long Term ICU Sedation Under 0,5 MAC Isoflurane, Sevoflurane or Desflurane Using MIRUS, an Automated Delivery System for Volatile Anaesthetics

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Ruhr University of Bochum · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The MIRUS system (TIM, Andernach, Germany) as well as the AnaConDa uses a reflector to conserve volatile anaesthetics (VA). Both systems can be paired with ICU ventilators, but MIRUS features an automated control of end-tidal VA concentrations (etVA). We compare depth of 0.5 MAC inhalational long-term sedation with Isoflurane (ISO), Sevoflurane (SEVO) or Desflurane (DES).

Detailed description

The study was approved by the appropriate Institutional Review Board. Thirty ASA II-IV patients, undergoing elective or emergency surgery under general anaesthesia were included and randomized into three equal groups: ISO, SEVO or DES. We used MIRUS, a gas delivery system with a VA reflector, just like AnaConDa, that can be paired with common ICU ventilators. Additionally, MIRUS features the unique ability to maintain the end-tidal concentration (etVA) in target by automatically adjusting the delivery rate. Every 8 hours, the RASS was assessed by the nurse. The log of the EEG-Narcotrend Index (NI) was also included in the study.

Conditions

Interventions

TypeNameDescription
DRUGIsofluraneGroup A: Isoflurane (0.5 MAC)
DRUGSevofluraneGroup B: Sevoflurane (0.5 MAC)
DRUGDesfluraneGroup C: Desflurane (0.5 MAC)

Timeline

Start date
2014-12-10
Primary completion
2017-05-05
Completion
2017-05-31
First posted
2019-03-01
Last updated
2019-03-01

Source: ClinicalTrials.gov record NCT03860129. Inclusion in this directory is not an endorsement.